跳至正文
OpenAgentSkill
浏览已开放 · 目录记录日期 2026-11-21 · 自动更新和账户服务暂时关闭。
数据与分析

claw-methylation-cycle

Methylation cycle analysis — enzymatic activity profiles, Net Methylation Capacity, BH4 axis estimates, compound heterozygosity detection from SNP genotype data.

ClawBio · 已有 AI 审核记录

安装与使用

运行命令前先阅读来源与依赖说明。复制命令不会自动安装或执行。

npx skills add ClawBio/ClawBio --skill claw-methylation-cycle

技能说明


name: claw-methylation-cycle license: MIT metadata: openclaw: requires: bins: - python3 env: null config: null always: false emoji: 🧬 homepage: https://github.com/ClawBio/ClawBio os: - darwin - linux install: 'pip install -e .

  '
trigger_keywords:
- methylation
- MTHFR
- folate cycle
- BH4
- homocysteine
- methylation cycle
- metilación
- neurotransmitter synthesis

author: Samuel Carmona Aguirre samuel@unimed-consulting.es demo_data_path: demo_input.txt dependencies_python: '>=3.9' guideline_doi: 10.3390/nu13030768 input_format: 23andme, adntro, ancestry output_format: markdown, json tags:

  • genomics
  • methylation
  • MTHFR
  • neurodevelopment trigger_keywords:
  • methylation
  • MTHFR
  • folate cycle
  • BH4
  • homocysteine
  • methylation cycle
  • metilación
  • neurotransmitter synthesis validation_tier: community version: 0.1.3 description: Methylation cycle analysis — enzymatic activity profiles, Net Methylation Capacity, BH4 axis estimates, compound heterozygosity detection from SNP genotype data.

claw-methylation-cycle

Methylation cycle analysis skill for ClawBio. Produces enzymatic activity profiles, Net Methylation Capacity (NMC), BH4 axis estimates, compound heterozygosity detection, and clinician-review genotype findings from raw SNP genotype data.


Trigger

Fire this skill when:

  • The user asks about methylation, MTHFR variants, folate cycle, or homocysteine risk from a genotype file.
  • A raw SNP file (23andMe / ADNTRO / Ancestry format) is provided and the clinical question involves methylation, BH4, dopamine/serotonin synthesis capacity, or neurodevelopmental contexts (ADHD, depression, anxiety).
  • The upstream workflow (PharmGx Reporter, NutriGx Advisor) has flagged MTHFR or MTRR and the clinician needs the full methylation panel.
  • Keywords present: methylation, MTHFR, BH4, folate cycle, metilación, ciclo de metilación, homocysteine, 5-MTHF, methylcobalamin, neurotransmitter synthesis, dopamine upstream.

Do NOT fire this skill when:

  • The question is purely about folic acid supplementation without a genotype file.
  • The user is asking about MTHFR in the context of thrombophilia/clotting only — use PharmGx Reporter for warfarin/anticoagulation questions.
  • Only N-GENE polygenic risk data is available (no raw SNP file) — this skill requires genotype-level input; PRS percentiles are not sufficient.
  • The SNP file format is VCF, FASTQ, BAM, or PLINK binary — these require preprocessing before this skill can run.
  • The clinical question is exclusively pharmacogenomic (CYP enzymes) — use PharmGx Reporter instead.

Workflow

  1. Receive input — Accept either a raw genotype file path or a pre-parsed snp_dict. If a file is provided, call parse_genotype_file() to extract the rsID → genotype mapping.

  2. Panel coverage check — Compare detected rsIDs against the 9-gene methylation panel. Log missing SNPs. For any SNP absent from the input, mark the corresponding gene as not_assessed — do NOT silently assume normal activity (Safety Rule 6).

  3. Enzymatic activity scoring — For each gene, map the diplotype to an estimated activity percentage. Heterozygous risk variants reduce activity by their assigned weight; homozygous variants apply the full reduction.

  4. Compound heterozygosity detection — Check MTHFR C677T (rs1801133) and A1298C (rs1801131) simultaneously. If both are heterozygous, set compound_heterozygosity = True and apply the combined activity reduction (~15% of normal — more severe than either variant alone).

  5. Net Methylation Capacity (NMC) — Compute the weighted average of all enzyme activities. Clamp to [0, 100]. Expose coverage_pct and snps_missing; flag NMC as partial if key SNPs are absent.

  6. BH4 axis capacity — Derive BH4 from MTHFR activity and MTRR modifier. Report clinical implications for dopamine and serotonin synthesis in neurodevelopmental presentations.

  7. Prioritised recommendations — Generate PRIORITY 1 / 2 / 3 recommendations based on active findings. Lead with highest clinical impact (compound het MTHFR or severely reduced BH4).

  8. Output — Write report.md (human-readable) and result.json (structured, for downstream integration).


Example Output

╔══════════════════════════════════════════════════════════════╗
║  ClawBio · Methylation Cycle Analysis Report                 ║
║  Author: Samuel Carmona Aguirre · RUO — Not a medical device ║
╚══════════════════════════════════════════════════════════════╝

Executive Summary
─────────────────
Net Methylation Capacity : 53 / 100  🔴 Reduced
BH4 Axis Capacity        : 31 / 100  🔴 Reduced
MTHFR Compound Het.      : YES ⚠️   (C677T + A1298C)
Dopamine Synthesis       : Severely Reduced
Serotonin Synthesis      : Severely Reduced

Enzymatic Activity Profile
──────────────────────────
Gene    Activity  Status                Key Variants
MTHFR    15%     🔴 Severely reduced   C677T, A1298C
MTRR     60%     🟡 Moderately reduced A66G
MTR     100%     🟢 Normal             –
CBS     100%     🟢 Normal             –
BHMT     40%     🔴 Moderately reduced R239Q
SHMT1    80%     🟢 Mildly reduced     C1420T
COMT     55%     🟡 Moderately reduced Val158Met
AHCY    100%     🟢 Normal             –

Clinical Recommendations — FOR CLINICIAN REVIEW ONLY
──────────────────────────────────────────────────────
⚠️  The following is genotype-based information for qualified clinician use.
    Do not self-administer. All nutrients listed are reported in the peer-reviewed
    literature for the pathways indicated; dosing and indication require
    individualised clinical assessment.

Genotype findings:
  • 5-MTHF (methylfolate) preferred over synthetic folic acid (MTHFR C677T/A1298C).
    Ref: Lamers Y et al. (20
阅读完整来源 ↗